Ignite Creation Date:
2025-12-25 @ 2:35 AM
Ignite Modification Date:
2026-04-23 @ 2:15 PM
Study NCT ID:
NCT02767934
Status:
TERMINATED
Last Update Posted:
2020-08-20
First Post:
2016-05-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab in Treating Minimal Residual Disease in Patients With Acute Lymphoblastic Leukemia
Sponsor:
University of Washington
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-13
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-17
Completion Date Type:
ACTUAL
First Submit Date:
2016-05-06
First Submit QC Date:
None
Study First Post Date:
2016-05-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-07-20
Results First Submit QC Date:
None
Results First Post Date:
2020-08-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-11
Last Update Post Date:
2020-08-20
Last Update Post Date Type:
ACTUAL